|
No, bob, twas not I who purchased the calls. I'm more into common stock than options. There's great news on the horizon I suspect. Perhaps the gene therapy deal finally has been closed. The REMUNE data was unblinded...maybe it's robust. Perhaps we'll get some other deal with a big pharmaceutical company (for RA, REMUNE, etc.)? Or maybe the company will shock us all and announce that the ph3 trial will be halted early, and fast-track fda approval will be sought. I don't personally think the trial will be halted early, but I've been wrong before. I really believe we'll get some good news thursday with regard to the partnering of the gene therapy stuff. And, of course, at month's end, I fully expect the world aids conf. to serve as a catalyst to move the stock price upwards. At that time, wall st. may realize the paradigm shift of the medical community, and may follow. Tomorrow is Tuesday, so perhaps some more press on remune data is in store. Nothing will shock me, so go imnr, go. Good luck. |
